Albert David (ALBERTDAVD.NS) Stock Price

Albert David Price

CLOSED
831.00
​
Market closed

Revenue has compounded at 5.0% per year over the past 18 years to 3.46 B INR. Earnings per share have grown at 1.5% per year over the last 18 years. Albert David's net margin stands at 5.0%, down from 8.9% several years earlier. Albert David currently offers a dividend yield of about 0.60%. The payout ratio is around 17% of earnings.

Albert David stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Albert David business model & stock analysis

Albert David Ltd, headquartered in Kolkata, West Bengal, operates in the Pharmaceuticals sector within the Health Care industry. The company manufactures and trades pharmaceutical products, including parenteral, oral/enteral, topical agents, and vision care solutions. It employs 1,271 full-time staff and has a global presence across Southeast Asia, Africa, the Middle East, Europe, the United States, and Latin America. Listed on 14 June 2016, the firm offers a diverse range of products such as amino acid infusions, antimicrobials, anti-leishmaniasis treatments, and anti-glaucoma medications.

Frequently asked questions about Albert David

7 analysts currently rate the Albert David stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Albert David share trades at 7.79 EUR (831.00 INR).

The revenue cannot currently be calculated for Albert David.

The profit cannot currently be calculated for Albert David.

The P/E ratio cannot be calculated for Albert David at the moment.

The P/S cannot be calculated for Albert David currently.

The Eulerpool Quality Score for Albert David is 2/10.

The ISIN of Albert David is INE155C01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Albert David is ALBERTDAVD.NS. The ticker symbol is used to trade Albert David shares on the stock exchange.

Fair ValueTerminal
880.86 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
2.72 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jun 14, 2016
ISIN
INE155C01010
Cusip
Y0030C118
Market capitalization
4.75 B INRMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.21
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.26 %
Dividend
Dividend yield
0.60 %
Payout Ratio
16.59 %
Dividend growth Ø5Y
-6.51 %
Dividend payments per year
1
Dividend paid since
9 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 18, 2026, 1:41 AM

Albert David Peer Group

Albert David FIGI

ALBRT:IN · BBG000CMZP49ALBRT:IB · BBG000CMZQ65ALBRT:IS · BBG000CMZQY4